• N/A
    Market Cap
  • -72.95%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
Income Statement
Total Operating Revenue
165,645
N/A
N/A
N/A
Cost of Revenue
115,397
N/A
N/A
N/A
Gross Profit
50,248
N/A
0
N/A
Sales and Marketing Expense
204,077
+1,021.30%
18,200
N/A
Research and Development Expense
-628,606
+127.71%
-276,057
N/A
Depreciation and Amortization Expense
1.2M
+0.91%
1.2M
N/A
Total Operating Expenses
N/A
N/A
N/A
N/A
Operating Profit
-5.5M
+86.54%
-2.9M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
-1.9M
+219.89%
-599,494
N/A
Interest Income and Expense and Net
-1.9M
+219.89%
-599,494
N/A
Total Nonoperating Income and Expense
403,393
+174.63%
146,884
N/A
Income before Taxes
-6.6M
+87.40%
-3.5M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-6.6M
+87.40%
-3.5M
N/A
Net Income from Continuing Operations Applicable to Common
-6.6M
+87.40%
-3.5M
N/A
Basic EPS and Net Income
-0.72
+63.64%
-0.44
N/A
Diluted EPS and Net Income
-0.72
+63.64%
-0.44
N/A
Basic Weighted Average Shares
9.3M
+14.22%
8.1M
N/A
Diluted Weighted Average Shares
9.3M
+14.22%
8.1M
N/A
Balance Sheet
Cash and Cash Equivalents
344,648
+1,305.46%
24,522
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
344,648
+1,305.46%
24,522
N/A
Total Current Assets
1.5M
+396.88%
303,227
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
15,907
-4.42%
16,642
N/A
Total Long-Term Assets
20.0M
-2.38%
20.5M
N/A
Total Assets
21.5M
+3.46%
20.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
4.2M
+101.71%
2.1M
N/A
Total Current Liabilities
5.6M
+45.68%
3.9M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
38,542
-97.83%
1.8M
N/A
Total Liabilities
5.7M
+0.45%
5.6M
N/A
Retained Earnings
N/A
N/A
N/A
N/A
Total Stockholders Equity
15.8M
+4.58%
15.1M
N/A
Total Shares Outstanding
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-5.5M
+415.81%
-1.1M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
-736,839
+397.29%
-148,170
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.5M
+664.69%
843,939
N/A
Financials Ratio
Gross Margin
30.33%
N/A
N/A
N/A
Operating Margin
-3,317.65%
N/A
N/A
N/A
Return on Assets
-31.47%
N/A
N/A
N/A
Return on Equity
-42.99%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
0.27
N/A
N/A
N/A
Cash Ratio
0.06
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow